Brought to you by Portland Press Ltd.
Published on behalf of the International Federation for Cell Biology
Cancer Cell death Cell cycle Cytoskeleton Exo/endocytosis Differentiation Division Organelles Signalling Stem cells Trafficking
Cell Biology International (2003) 27, 953–958 (Printed in Great Britain)
Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide
Y Zhang* and W.L Shen
Institute of Hematology, Medical College of Jinan University, Guangzhou 510632, China


Abstract

Cell culture, tissue chemistry and flow cytometry were used to determine whether antisense bcl-2 oligodeoxynucleotides enhanced the sensitivity of leukemia cells to arsenic trioxide. A combination of arsenic trioxide with antisense bcl-2 oligodeoxynucleotides inhibited cell growth, induced apoptosis and induced bcl-2 protein expression in K562 and NB4 leukemic cells more significantly than either arsenic trioxide or the oligodeoxynucleotides on their own (P<0.01). Thus, bcl-2 antisense oligodeoxynucleotides increase the sensitivity of leukemic cells to arsenic trioxide. Combined use of the two agents could be a novel and attractive strategy in leukemia treatment.


Key words: bcl-2, Apoptosis, Arsenic trioxide, Leukemia, Antisense oligonucleotide.

*Corresponding author. Tel.: +86-20-8522-6476; fax: +86-20-8522-1343


Received 24 January 2002/26 May 2003; accepted 8 July 2003

doi:10.1016/S1065-6995(03)00164-1


ISSN Print: 1065-6995
ISSN Electronic: 1095-8355
Published by Portland Press Limited on behalf of the International Federation for Cell Biology (IFCB)